Please use this identifier to cite or link to this item: https://observatorio.fm.usp.br/handle/OPI/1958
Full metadata record
DC FieldValueLanguage
dc.contributorSistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP-
dc.contributor.authorSANTOS, Marcos Eduardo Lera dos-
dc.contributor.authorMALUF-FILHO, Fauze-
dc.contributor.authorCHAVES, Dalton Marques-
dc.contributor.authorMATUGUMA, Sergio Eiji-
dc.contributor.authorIDE, Edson-
dc.contributor.authorLUZ, Gustavo de Oliveira-
dc.contributor.authorSOUZA, Thiago Ferreira de-
dc.contributor.authorPESSORRUSSO, Fernanda C. Simoes-
dc.contributor.authorMOURA, Eduardo Guimaraes Hourneaux de-
dc.contributor.authorSAKAI, Paulo-
dc.date.accessioned2013-09-23T16:39:15Z-
dc.date.available2013-09-23T16:39:15Z-
dc.date.issued2013-
dc.identifier.citationWORLD JOURNAL OF GASTROENTEROLOGY, v.19, n.22, p.3439-3446, 2013-
dc.identifier.issn1007-9327-
dc.identifier.urihttps://observatorio.fm.usp.br/handle/OPI/1958-
dc.description.abstractAIM: To compare deep sedation with propofol-fentanyl and midazolam-fentanyl regimens during upper gastrointestinal endoscopy. METHODS: After obtaining approval of the research ethics committee and informed consent, 200 patients were evaluated and referred for upper gastrointestinal endoscopy. Patients were randomized to receive propofol-fentanyl or midazolam-fentanyl (n = 100/group). We assessed the level of sedation using the observer's assessment of alertness/sedation (OAA/S) score and bispectral index (BIS). We evaluated patient and physician satisfaction, as well as the recovery time and complication rates. The statistical analysis was performed using SPSS statistical software and included the Mann-Whitney test, chi(2) test, measurement of analysis of variance, and the kappa statistic. RESULTS: The times to induction of sedation, recovery, and discharge were shorter in the propofol-fentanyl group than the midazolam-fentanyl group. According to the OAA/S score, deep sedation events occurred in 25% of the propofol-fentanyl group and 11% of the midazolam-fentanyl group (P = 0.014). Additionally, deep sedation events occurred in 19% of the propofol-fentanyl group and 7% of the midazolam-fentanyl group according to the BIS scale (P = 0.039). There was good concordance between the OAA/S score and BIS for both groups (kappa = 0.71 and kappa = 0.63, respectively). Oxygen supplementation was required in 42% of the propofol-fentanyl group and 26% of the midazolam-fentanyl group (P = 0.025). The mean time to recovery was 28.82 and 44.13 min in the propofol-fentanyl and midazolam-fentanyl groups, respectively (P < 0.001). There were no severe complications in either group. Although patients were equally satisfied with both drug combinations, physicians were more satisfied with the propofol-fentanyl combination. CONCLUSION: Deep sedation occurred with propofol-fentanyl and midazolam-fentanyl, but was more frequent in the former. Recovery was faster in the propofol-fentanyl group.-
dc.language.isoeng-
dc.publisherBAISHIDENG PUBL GRP CO LTD-
dc.relation.ispartofWorld Journal of Gastroenterology-
dc.rightsopenAccess-
dc.subjectEndoscopy-
dc.subjectDeep sedation-
dc.subjectAnesthetic administration-
dc.subjectAnesthetic dose-
dc.subjectAdverse effects-
dc.subject.otherrandomized controlled-trial-
dc.subject.othergi endoscopy-
dc.subject.othernon-anesthesiologists-
dc.subject.otherconscious sedation-
dc.subject.othercomparing propofol-
dc.subject.othermoderate sedation-
dc.subject.othernationwide survey-
dc.subject.otherguidelines-
dc.subject.othernurses-
dc.subject.othergastroenterologist-
dc.titleDeep sedation during gastrointestinal endoscopy: Propofol-fentanyl and midazolam-fentanyl regimens-
dc.typearticle-
dc.rights.holderCopyright BAISHIDENG PUBL GRP CO LTD-
dc.identifier.doi10.3748/wjg.v19.i22.3439-
dc.identifier.pmid23801836-
dc.subject.wosGastroenterology & Hepatology-
dc.type.categoryoriginal article-
dc.type.versionpublishedVersion-
hcfmusp.author.externalMALUF-FILHO, Fauze:Univ Sao Paulo, Sch Med, Hosp Clin, Dept Gastroenterol, BR-05403900 Sao Paulo, Brazil; Canc Inst Sao Paulo State, BR-01246000 Sao Paulo, Brazil-
hcfmusp.author.externalMATUGUMA, Sergio Eiji:Univ Sao Paulo, Sch Med, Hosp Clin, Dept Gastroenterol, BR-05403900 Sao Paulo, Brazil; Canc Inst Sao Paulo State, BR-01246000 Sao Paulo, Brazil-
hcfmusp.author.externalPESSORRUSSO, Fernanda C. Simoes:Univ Sao Paulo, Sch Med, Hosp Clin, Dept Gastroenterol, BR-05403900 Sao Paulo, Brazil-
hcfmusp.description.beginpage3439-
hcfmusp.description.endpage3446-
hcfmusp.description.issue22-
hcfmusp.description.volume19-
hcfmusp.origemWOS-
hcfmusp.origem.id2-s2.0-84879049236-
hcfmusp.origem.idWOS:000320375400009-
hcfmusp.publisher.cityWANCHAI-
hcfmusp.publisher.countryPEOPLES R CHINA-
hcfmusp.relation.referenceBenson AA, 2008, GUT LIVER, V2, P105, DOI 10.5009/gnl.2008.2.2.105-
hcfmusp.relation.referenceBower AL, 2000, GASTROINTEST ENDOSC, V52, P192, DOI 10.1067/mge.2000.107284-
hcfmusp.relation.referenceCARVALHO PHB, 2008, TRATADO ENDOSCOPIA D, V4, P37-
hcfmusp.relation.referenceChen SC, 2004, ALIMENT PHARM THERAP, V19, P147, DOI 10.1111/j.0269-2813.2004.01833.x-
hcfmusp.relation.referenceCHERNIK DA, 1990, J CLIN PSYCHOPHARM, V10, P244-
hcfmusp.relation.referenceCohen Lawrence B, 2008, Gastrointest Endosc Clin N Am, V18, P651, DOI 10.1016/j.giec.2008.06.015-
hcfmusp.relation.referenceCohen LB, 2004, GASTROINTEST ENDOSC, V59, P795, DOI 10.1016/S0016-5107(04)00349-9-
hcfmusp.relation.referenceCohen LB, 2010, ALIMENT PHARM THER, V32, P425, DOI 10.1111/j.1365-2036.2010.04352.x-
hcfmusp.relation.referenceCOHEN LB, 2008, GASTROINTEST ENCLOSE, V18, pR7, DOI 10.1016/J.GIEC.2008.06.015]-
hcfmusp.relation.referenceCohen LB, 2003, GASTROINTEST ENDOSC, V58, P725, DOI 10.1016/S0016-5107(03)02010-8-
hcfmusp.relation.referenceCohen LB, 2006, AM J GASTROENTEROL, V101, P967, DOI 10.1111/j.1572-0241.2006.00500.x-
hcfmusp.relation.referenceCohen LB, 2007, GASTROENTEROLOGY, V133, P675, DOI 10.1053/j.gastro.2007.06.002-
hcfmusp.relation.referenceCorreia LM, 2011, GASTROINTEST ENDOSC, V73, P45, DOI 10.1016/j.gie.2010.09.025-
hcfmusp.relation.referenceDEAZEVEDO MP, 2005, MED PERIOPERATORIA, V81, P709-
hcfmusp.relation.referenceDeWitt JM, 2008, DIGEST DIS SCI, V53, P2739, DOI 10.1007/s10620-008-0198-x-
hcfmusp.relation.referenceDinis-Ribeiro M, 2010, DIGESTION, V82, P100, DOI 10.1159/000287215-
hcfmusp.relation.referenceDrake LM, 2006, AM J GASTROENTEROL, V101, P2003, DOI 10.1111/j.1572-0241.2006.00806.x-
hcfmusp.relation.referenceDumonceau JM, 2010, ENDOSCOPY, V42, P960, DOI 10.1055/s-0030-1255728-
hcfmusp.relation.referenceFaigel DO, 2002, GASTROINTEST ENDOSC, V56, P613-
hcfmusp.relation.referenceFanti L, 2010, WORLD J GASTROENTERO, V16, P2451, DOI 10.3748/wjg.v16.i20.2451-
hcfmusp.relation.referenceGross JB, 2002, ANESTHESIOLOGY, V96, P1004-
hcfmusp.relation.referenceHeuss Ludwig T, 2008, Gastrointest Endosc Clin N Am, V18, P727, DOI 10.1016/j.giec.2008.06.007-
hcfmusp.relation.referenceHEUSS LT, 2008, GASTROINTEST ENDOSC, V18, pR9-
hcfmusp.relation.referenceImagawa A, 2008, ENDOSCOPY, V40, P905, DOI 10.1055/s-2008-1077641-
hcfmusp.relation.referenceLichtenstein DR, 2008, GASTROINTEST ENDOSC, V68, P815, DOI 10.1016/j.gie.2008.09.029-
hcfmusp.relation.referenceMcQuaid KR, 2008, GASTROINTEST ENDOSC, V67, P910, DOI 10.1016/j.gie.2007.12.046-
hcfmusp.relation.referenceMeining A, 2007, ENDOSCOPY, V39, P345, DOI 10.1055/s-2006-945195-
hcfmusp.relation.referenceMOSES PL, 2004, GASTROINTEST E S1574, V59, P130, DOI 10.1016/S0016-5107-
hcfmusp.relation.referencePaspatis GA, 2009, ENDOSCOPY, V41, P1046, DOI 10.1055/s-0029-1215342-
hcfmusp.relation.referencePatel S, 2005, AM J GASTROENTEROL, V100, P2689, DOI 10.1111/j.1572-0241.2005.00320.x-
hcfmusp.relation.referenceQadeer MA, 2008, CLIN GASTROENTEROL H, V6, P102, DOI 10.1016/j.cgh.2007.10.005-
hcfmusp.relation.referenceRex DK, 2002, AM J GASTROENTEROL, V97, P1159-
hcfmusp.relation.referenceRex DK, 2006, ALIMENT PHARM THERAP, V24, P163, DOI 10.1111/j.1365-2036.2006.02986.x-
hcfmusp.relation.referenceRiphaus A, 2010, Z GASTROENTEROL, V48, P392, DOI 10.1055/s-0028-1109765-
hcfmusp.relation.referenceSipe BW, 2002, GASTROINTEST ENDOSC, V55, P815, DOI 10.1067/mge.2002.124636-
hcfmusp.relation.referenceTan Gang, 2010, F1000 Med Rep, V2, P79, DOI 10.3410/M2-79-
hcfmusp.relation.referenceThomson A, 2010, J GASTROEN HEPATOL, V25, P469, DOI 10.1111/j.1440-1746.2009.06174.x-
hcfmusp.relation.referenceVargo JJ, 2009, GASTROINTEST ENDOSC, V70, P1053, DOI 10.1016/j.gie.2009.07.020-
hcfmusp.relation.referenceWaring JP, 2003, GASTROINTEST ENDOSC, V58, P317, DOI 10.1067/S0016-5107(03)00001-4-
dc.description.indexMEDLINE-
hcfmusp.citation.scopus42-
hcfmusp.scopus.lastupdate2024-04-12-
Appears in Collections:

Artigos e Materiais de Revistas Científicas - FM/MGT
Departamento de Gastroenterologia - FM/MGT

Artigos e Materiais de Revistas Científicas - HC/ICHC
Instituto Central - HC/ICHC

Artigos e Materiais de Revistas Científicas - HC/InCor
Instituto do Coração - HC/InCor

Artigos e Materiais de Revistas Científicas - LIM/35
LIM/35 - Laboratório de Nutrição e Cirurgia Metabólica do Aparelho Digestivo


Files in This Item:
File Description SizeFormat 
art_SANTOS_Deep_sedation_during_gastrointestinal_endoscopy_Propofol_fentanyl_and_2013.PDFpublishedVersion (English)887.81 kBAdobe PDFThumbnail
View/Open

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.